This inventor holds 2 USPTO granted patents. Top assignee: Fusion Antibodies Limited. Active years: 2011-2014.
Company Filing History:
Years Active: 2011-2014
Title: Jim Johnston: Innovator in Antibody Research
Introduction
Jim Johnston is a notable inventor based in Belfast, Ireland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 2 patents, Johnston's work focuses on innovative solutions for treating diseases linked to cathepsin S activity.
Latest Patents
Johnston's latest patents include groundbreaking research on antibodies and their uses. These specific binding members, such as antibodies, are designed to treat diseases associated with cathepsin S activity. The binding members effectively inhibit the proteolytic activity of cathepsin S. This innovation holds promise for treating various conditions, including cancer, inflammatory diseases, neurodegenerative disorders, autoimmune disorders, and other diseases related to excessive or inappropriate angiogenesis.
Career Highlights
Jim Johnston is currently associated with Fusion Antibodies Limited, where he continues to advance his research in antibody development. His work has positioned him as a key figure in the biotechnology sector, contributing to the understanding and treatment of complex diseases.
Collaborations
Johnston collaborates with talented individuals such as Christopher Scott and Roberta Burden, enhancing the innovative environment at Fusion Antibodies Limited. Their combined expertise fosters a culture of creativity and scientific advancement.
Conclusion
Jim Johnston's contributions to antibody research exemplify the impact of innovation in biotechnology. His patents and ongoing work continue to pave the way for new therapeutic approaches to challenging diseases.